Science Explorer Back to mapMap
Discussion
Company · Tübingen · Germany

CureVac (Germany)

curevac.comROR OpenAlex
Research works
67
▲ 20% vs 2018-21
Citations
5.3k
77.9 per fractional work
Top-10% rate
16.0%
all institutions 10.0%
Open access
64%
world 40%
International
31%
world 18%
CureVac (Germany)

Not ranked overall: CureVac (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does CureVac (Germany) work in?

In all years, 66% of research at CureVac (Germany) is in Life Sciences, 28% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (35%), Medicine (27%), Immunology and Microbiology (26%). It does 3.6× the world's share of Life Sciences.

Life Sciences: 44 fractional works · 65.6% of its workBiochemistry, Genetics and Molecular Biology: 24 fractional works · 35.0% of its workMolecular Biology: 17 fractional works · 25.4% of its workGenetics: 4 fractional works · 5.8% of its workBiotechnology: 1 fractional works · 1.2% of its workCancer Research: 1 fractional works · 0.8% of its workCell Biology: 0 fractional works · 0.5% of its workEndocrinology: 0 fractional works · 0.5% of its workBiophysics: 0 fractional works · 0.4% of its workClinical Biochemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 18 fractional works · 26.3% of its workImmunology: 16 fractional works · 23.2% of its workVirology: 1 fractional works · 2.0% of its workMicrobiology: 1 fractional works · 0.9% of its workParasitology: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 3 fractional works · 4.0% of its workAnimal Science and Zoology: 2 fractional works · 3.3% of its workPlant Science: 0 fractional works · 0.4% of its workInsect Science: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.2% of its workHealth Sciences: 19 fractional works · 27.6% of its workMedicine: 19 fractional works · 27.5% of its workInfectious Diseases: 8 fractional works · 12.2% of its workOncology: 3 fractional works · 4.8% of its workEpidemiology: 2 fractional works · 2.7% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.1% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.1% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.8% of its workNeurology: 0 fractional works · 0.5% of its workHepatology: 0 fractional works · 0.4% of its workDermatology: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 1.0% of its workVeterinary: 0 fractional works · 0.2% of its workPhysical Sciences: 3 fractional works · 4.9% of its workEngineering: 1 fractional works · 1.6% of its workBiomedical Engineering: 1 fractional works · 1.6% of its workEnvironmental Science: 1 fractional works · 1.0% of its workEcology: 1 fractional works · 0.8% of its workWater Science and Technology: 0 fractional works · 0.2% of its workMaterials Science: 1 fractional works · 1.0% of its workBiomaterials: 1 fractional works · 1.0% of its workChemistry: 0 fractional works · 0.5% of its workOrganic Chemistry: 0 fractional works · 0.5% of its workMathematics: 0 fractional works · 0.5% of its workModeling and Simulation: 0 fractional works · 0.5% of its workComputer Science: 0 fractional works · 0.4% of its workComputational Theory and Mathematics: 0 fractional works · 0.4% of its workSocial Sciences: 1 fractional works · 1.9% of its workSocial Sciences: 1 fractional works · 0.8% of its workPolitical Science and International Relations: 0 fractional works · 0.5% of its workHealth: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.6% of its workEconomics and Econometrics: 0 fractional works · 0.6% of its workArts and Humanities: 0 fractional works · 0.4% of its workHistory: 0 fractional works · 0.4% of its workPsychology: 0 fractional works · 0.2% of its workALL ITS WORKCureVac (Germany)67fractional works, all years
Life Sciences66%Physical Sciences5%Health Sciences28%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2435.0%
    2. Immunology and Microbiology1826.3%
    3. Agricultural and Biological Sciences34.0%
    4. Neuroscience00.2%
    1. Medicine1927.5%
    2. Veterinary00.2%
    1. Engineering11.6%
    2. Environmental Science11.0%
    3. Materials Science11.0%
    4. Chemistry00.5%
    5. Mathematics00.5%
    6. Computer Science00.4%
    1. Social Sciences10.8%
    2. Economics, Econometrics and Finance00.6%
    3. Arts and Humanities00.4%
    4. Psychology00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.75× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.84× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 21.39× its world share, 4 worksImmunology and Micro…Chemistry: 1.13× its world share, 0 worksChemistryComputer Science: 0.17× its world share, 0 worksComputer ScienceEngineering: 0.19× its world share, 1 worksEngineeringEnvironmental Science: 0.07× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.51× its world share, 0 worksMaterials ScienceMathematics: 0.19× its world share, 0 worksMathematicsMedicine: 1.80× its world share, 6 worksMedicineEconomics, Econometrics and Finance: 0.10× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.09× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 21.4×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Immunology and Microbiology21.39×4 works
  2. Biochemistry, Genetics and Molecular Biology4.84×5 works
  3. Medicine1.80×6 works
  4. Agricultural and Biological Sciences1.75×2 works
  5. Chemistry1.13×0 works
  6. Materials Science0.51×0 works
  7. Engineering0.19×1 works
  8. Mathematics0.19×0 works
  9. Computer Science0.17×0 works
  10. Economics, Econometrics and Finance0.10×0 works
  11. Social Sciences0.09×0 works
  12. Environmental Science0.07×0 works

Who are the top researchers at CureVac (Germany)?

Ranked on the quality score, Mariola Fotin‐Mleczek, Benjamin Petsch and Andreas Theß lead among researchers whose main affiliation is CureVac (Germany).

  1. 1 Mariola Fotin‐Mleczek Germany · #132,515 worldwide 7k citations · 55 works
  2. 2 Benjamin Petsch Germany · #134,841 worldwide 3.2k citations · 55 works
  3. 3 Andreas Theß Germany · #135,276 worldwide 15k citations · 38 works
  4. 4 Susanne Rauch Germany · #371,867 worldwide 2.4k citations · 43 works
  5. 5 Ingmar Hoerr Germany · #442,666 worldwide 3.2k citations · 25 works
  6. 6 Birgit Scheel Germany · #444,842 worldwide 3.4k citations · 47 works
  7. 7 Regina Heidenreich Germany · #489,270 worldwide 3.5k citations · 81 works
  8. 8 Karl‐Josef Kallen Germany · #551,663 worldwide 5.4k citations · 67 works
  9. 9 Sven Dominik Koch Germany · #612,988 worldwide 3.4k citations · 78 works
  10. 10 Patrick Baumhof Germany · #650,905 worldwide 1.8k citations · 15 works
All ranked researchers at CureVac (Germany)

What are the most cited papers from CureVac (Germany)?

The most cited paper from CureVac (Germany) is "Developing mRNA-vaccine technologies" (Thomas Schlake, Andreas Theß, Mariola Fotin‐Mleczek et al., 2012), with 638 citations. Next come "New Vaccine Technologies to Combat Outbreak Situations" (598) and "Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial" (544).

Most cited papers
#PaperReleasedCitations
1 Developing mRNA-vaccine technologies Thomas Schlake, Andreas Theß, Mariola Fotin‐Mleczek et al. · RNA Biology Open access 12 Oct 2012 638
2 New Vaccine Technologies to Combat Outbreak Situations Susanne Rauch, Edith Jasny, Kim E. Schmidt et al. · Frontiers in Immunology Open access 19 Sep 2018 598
3 Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial Martin Alberer, Ulrike Gnad-Vogt, Henoch Sangjoon Hong et al. · The Lancet 25 Jul 2017 544
4 Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals Andreas Theß, Stefanie E. Grund, Barbara L. Mui et al. · Molecular Therapy Open access 8 Jun 2015 528
5 Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection Benjamin Petsch, Margit Schnee, Annette B. Vogel et al. · Nature Biotechnology 18 Nov 2012 470
All 60 most cited papers, with filters and sorting

Which keywords describe research at CureVac (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Immunity, Gene Silencing, RNA Interference, siRNA Delivery, Vaccine, Cancer Immunotherapy and Innate Immunity.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Gene Therapy15▲ 83×4 topics
  2. Immunity12▲ 55×5 topics
  3. Epidemiology11▲ 4.0×21 topics
  4. Gene Silencing11▲ 132×2 topics
  5. RNA Interference11▲ 141×1 topic
  6. siRNA Delivery11▲ 210×1 topic
  7. Vaccine10▲ 39×9 topics
  8. Cancer Immunotherapy10▲ 106×2 topics
  9. Innate Immunity10▲ 41×3 topics
  10. Antigen Presentation9▲ 135×2 topics
  11. Dendritic Cells9▲ 115×1 topic
  12. Tumor Antigen9▲ 163×1 topic
  13. Pathogenesis8▲ 22×9 topics
  14. Immune Response6▲ 13×9 topics
  15. Coronavirus5▲ 66×2 topics
  16. Pandemic4▲ 14×5 topics
  17. SARS-CoV-24▲ 42×4 topics
  18. ACE2 Receptor4▲ 48×2 topics
  19. Inflammation4▲ 2.3×10 topics
  20. Genomic Integration3▲ 48×2 topics
  21. Viral Transmission3▲ 52×2 topics
  22. Pattern Recognition Receptors3▲ 34×2 topics
  23. AAV3▲ 73×1 topic
  24. Viral Vectors3▲ 73×1 topic
  25. Infection3▲ 16×3 topics
  26. Mutation3▲ 28×2 topics
  27. Pathogen Recognition3▲ 50×2 topics
  28. antibody3▲ 100×1 topic
  29. spike protein3▲ 100×1 topic
  30. Norovirus3▲ 75×1 topic
  31. Rotavirus3▲ 75×1 topic
  32. Innate Antiviral Responses3▲ 60×1 topic
  33. Metagenomics3▲ 33×2 topics
  34. Toll-like Receptors3▲ 24×1 topic
  35. Immunotherapy3▲ 6.0×9 topics
  36. Genomic Sequencing2▲ 25×2 topics
  37. Circovirus2▲ 92×1 topic
  38. Porcine Reproductive and Respiratory Syndrome Virus2▲ 92×1 topic
  39. Monoclonal Antibodies2▲ 20×2 topics
  40. Tumor Regression2▲ 31×2 topics

Which research topics does CureVac (Germany) publish most on?

By volume in 2022-now: RNA Interference and Gene Delivery, SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses and Animal Virus Infections Studies.

RNA Interference and Gene Delivery: 2 fractional worksSARS-CoV-2 and COVID-19 Research: 2 fractional worksImmunotherapy and Immune Responses: 2 fractional worksAnimal Virus Infections Studies: 1 fractional worksBiosimilars and Bioanalytical Methods: 1 fractional worksCOVID-19 Clinical Resear…1COVID-19 Clinical Research Studies: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksViral gastroenteritis research and epidemiology: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksAdvanced biosensing and bioanalysis techniques: 0 fractional works
Molecular BiologyInfectious DiseasesImmunologyAnimal Science and Zoology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 RNA Interference and Gene Delivery Molecular Biology 2 works
  2. 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 2 works
  3. 3 Immunotherapy and Immune Responses Immunology 2 works
  4. 4 Animal Virus Infections Studies Animal Science and Zoology 1 works
  5. 5 Biosimilars and Bioanalytical Methods Immunology 1 works
  6. 6 COVID-19 Clinical Research Studies Infectious Diseases 1 works
  7. 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
  9. 9 Cancer Immunotherapy and Biomarkers Oncology 0 works
  10. 10 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available64.5%not open35.5%

World: 40% of research is openly available.

with international co-authors30.6%domestic only69.4%

World: 18% is written across borders.

How has CureVac (Germany)'s research output changed?

Output in 2022-2025 was 20% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is CureVac (Germany) as a percentage of every work published that year, 0.00010% in 2024.

still counting0.000050%0.00010%0.00015%CureVac (Germany)0.000045% in 202520102020

Fractional works of CureVac (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Tübingen

All research institutions in Tübingen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about CureVac (Germany). Posts are plain text and can be reported.